Aziz Kabeer sold ANTX

January 16, 2024 · Form 4 insider transaction

Aziz Kabeer sold 84,093 shares of AN2 Therapeutics, Inc. at $19.65 per share, a transaction worth $1.65M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
84,093
Price
$19.65
Total value
$1.65M
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 16, 2024
Filing dateJanuary 18, 2024
Shares owned after1,995,958
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

View the original Form 4 on SEC EDGAR